Saito H, Hamilton S M, Tavill A S, Louis L, Ratnoff O D
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6837-40. doi: 10.1073/pnas.77.11.6837.
In view of conflicting evidence for a major hepatic role in the synthesis of circulating plasminogen, the precursor of the fibrinolytic enzyme plasmin, we carried out the present study with a sensitive assay in order to measure the accumulation of small quantities of plasminogen in a recycling rat liver perfusion system. We have purified plasminogen from Sprague-Dawley rat plasma and have raised a monospecific antiserum against it in rabbits. Isolated rat liver perfusions were performed with an oxygenated recycling perfusate consisting of a perfluorotributylamine/Pluronic F-68 emulsion (Fluosol 43) free of plasma proteins and blood cells. The system was shown to be capable of synthesizing albumin and transferrin. The cumulative appearance of plasminogen in the perfusate was measured by a sensitive, specific radioimmunoassay. Plasminogen concentration increased progressively during the first 2 hr of perfusion; the observed average net synthesis in five separate experiments was approximately 35 microgram/hr per 100 g of body weight. Exposure of the perfused liver to 18 microM cycloheximide inhibited additional increase in the titer of plasminogen. Evidence for de novo synthesis was provided by the incorporation of 14C-labeled leucine into specific immunoprecipitates of plasminogen and the inhibition of this incorporation by cycloheximide. Analysis of the immunoprecipitates by sodium dodecyl sulfate/polyacrylamide gel electrophoresis revealed a single peak of radioactivity corresponding to Mr of 82,000. These data indicate that the liver is a major site of plasminogen production.
鉴于关于肝脏在循环纤溶酶原(纤溶酶的前体)合成中起主要作用的证据相互矛盾,我们进行了本研究,采用灵敏的检测方法来测定在大鼠肝脏再循环灌注系统中少量纤溶酶原的积累情况。我们从斯普拉格-道利大鼠血浆中纯化了纤溶酶原,并在兔体内制备了针对它的单特异性抗血清。采用不含血浆蛋白和血细胞的全氟三丁胺/普朗尼克F-68乳剂(氟索43)作为充氧再循环灌注液对离体大鼠肝脏进行灌注。该系统被证明能够合成白蛋白和转铁蛋白。通过灵敏、特异的放射免疫分析法测定灌注液中纤溶酶原的累积出现量。在灌注的最初2小时内,纤溶酶原浓度逐渐升高;在五个独立实验中观察到的平均净合成量约为每100克体重35微克/小时。将灌注的肝脏暴露于18微摩尔的环己酰亚胺可抑制纤溶酶原滴度的进一步升高。14C标记的亮氨酸掺入纤溶酶原的特异性免疫沉淀物中,且环己酰亚胺可抑制这种掺入,这为从头合成提供了证据。通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳对免疫沉淀物进行分析,发现一个对应于分子量为82,000的放射性单峰。这些数据表明肝脏是纤溶酶原产生的主要部位。